NASDAQ · CHEMICALS & ALLIED PRODUCTS · LARGE CAP
Innospec Inc. IOSP
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY12 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$1.8B
▼ 3.7% vs FY2024
Dividend streak
12 yrs
Raised every year since 2014
EPS · FY25
$4.67
Dividend / sh · FY25
$1.71
Payout · FY25
36%
ROE · FY25
9.2%
Net margin · FY25
6.6%
Dividend coverage
2.7×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.8B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
7 cents of every revenue dollar became profit this year.
Per share
USD 4.67
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 2.7 times — the rest stayed in the company.
Profitability
9.2%
Return on equity, FY2025
ROE
Operating margin7.3%
Net margin6.6%
Return on assets6.5%
Each USD of equity produced 9 cents of profit this year.
Returned to shareholders
USD 66.3M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 42.4M
Net buybacksUSD 23.9M
Share of profit56.9%
Consecutive raises12 years
USD 42.4M in dividends and USD 23.9M in buybacks — 57% of the year's profit went back to shareholders.
Growth
+8.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−3.3%
+8.3%
+5.8%
+6.6%
Net income
−4.3%
+32.4%
−0.2%
+3.1%
EPS, diluted
−4.3%
+32.1%
−0.4%
+3.1%
Dividend / share
+10.1%
+10.5%
+10.9%
Returned to shareholders
+20.8%
+19.1%
+8.5%
+24.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.8B
total assets, end of FY2025
Total assetsUSD 1.8B
EquityUSD 1.3B
CashUSD 292.5M
Current ratio2.79×
Equity funds 72% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
1.8
1.8
1.9
2.0
1.5
1.2
1.5
1.5
1.3
0.9
1.0
1.0
0.8
0.8
0.8
0.7
0.6
Operating income $B
0.1
0.2
0.2
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.0
EBITDA $B
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.0
Income tax $B
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
EPS, diluted $
4.67
1.42
5.56
5.32
3.75
1.16
4.54
3.45
2.52
3.33
4.86
3.38
3.22
2.81
1.92
2.97
0.26
Dividend / sh $
1.71
1.55
1.41
1.28
1.16
1.04
1.02
0.89
0.77
0.67
0.61
0.55
0.50
2.00
0.00
0.00
0.05
Payout %
36
109
25
24
31
89
22
26
30
20
12
16
15
70
0
0
19
ROE %
9.2
3.0
12.7
12.8
9.4
3.1
12.9
10.5
8.5
12.9
21.3
18.2
21.4
20.3
14.6
32.2
4.1
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed